Peker, ErdalKirimi, ErcanTuncer, OguzCeylan, AbdullahOner, Ahmet F.2025-05-102025-05-1020090953-710410.3109/095371009032477902-s2.0-73649118824https://doi.org/10.3109/09537100903247790https://hdl.handle.net/20.500.14720/11819Giant hemangiomas are rare in newborn babies and may cause some life-threatening complications such as congestive heart failure and coagulopathies including severe thrombocytopenia, microangiopathic hemolytic anemia and bleeding such as Kasabach-Merritt syndrome. We have presented here one infant case with a right lower brachial plexus paralysis due to giant hemangioma treated successfully with interferon alpha and have discussed the treatment. This is the first case of Kasabach-Merritt syndrome associated with a right lower brachial plexus paralysis treated with interferon in the literature to our knowledge. The administration of interferon-alpha might be indicated as a therapy for severe, life-threatening and giant hemangiomas such as Kasabach-Merritt syndrome, especially when there is resistance to steroid. However, more extensive data and new patients are needed to clarify this issue.eninfo:eu-repo/semantics/closedAccessKasabach-Merritt SyndromeBrachial Plexus ParalysisInterferon AlphaTreatmentCavernous HemangiomaArticle208Q2Q160360519929246WOS:000272719400011